Novo Nordisk Halts Phase III Concizumab Hemophilia Trials After Three Thrombotic Events

 
• By Mandy Jackson
Hand above a red emergency button
Novo Nordisk halted three studies, including two Phase III trials • Source: Shutterstock

More from Clinical Trials

More from R&D